首页> 外文期刊>Surgical oncology >Future liver remnant function as a predictor of postoperative morbidity following liver resection for hepatocellular carcinoma - A risk factor analysis
【24h】

Future liver remnant function as a predictor of postoperative morbidity following liver resection for hepatocellular carcinoma - A risk factor analysis

机译:未来肝脏残留作用作为肝细胞癌肝切除术后术后发病率的预测因子 - 风险因素分析

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Advances in anaesthesia and surgical technique have considerably reduced mortality in hepatocellular carcinoma (HCC) patients undergoing liver resection. However, extended resections in patients with liver cirrhosis still represent a challenge. The aim of this study was to investigate the predictive value of volume/function analysis for the prediction of morbidity in HCC patients following liver resection.
机译:None

著录项

  • 来源
    《Surgical oncology》 |2020年第1期|共9页
  • 作者单位

    Charite Univ Med Berlin Campus Virchow Klinikum Dept Surg Augustenburger Pl 1 D-13353 Berlin;

    Charite Univ Med Berlin Campus Virchow Klinikum Dept Surg Augustenburger Pl 1 D-13353 Berlin;

    Charite Univ Med Berlin Campus Virchow Klinikum Dept Surg Augustenburger Pl 1 D-13353 Berlin;

    Martin Luther Krankenhaus Dept Gen Visceral Vasc Surg Caspar Theyss Str 27-31 D-14193 Berlin;

    Charite Univ Med Berlin Campus Virchow Klinikum Dept Surg Augustenburger Pl 1 D-13353 Berlin;

    Charite Univ Med Berlin Campus Virchow Klinikum Dept Surg Augustenburger Pl 1 D-13353 Berlin;

    Charite Univ Med Berlin Campus Virchow Klinikum Dept Surg Augustenburger Pl 1 D-13353 Berlin;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

    Hepatocellular carcinoma; Morbidity; LiMAx;

    机译:肝细胞癌;发病率;Limax;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号